MARY KING: Open Payments
NPI 1245728203 · CENTENNIAL, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,427 in 70 payments from 22 companies in 2025. Trend: 2023 $1,264 · 2024 $988 · 2025 $1,427
Food & beverage: $1,427
| Company | Payments | Amount |
|---|---|---|
| Cycle Pharmaceuticals Inc | 11 | $249 |
| BioCryst US Sales Co., LLC | 15 | $202 |
| GENZYME CORPORATION | 11 | $196 |
| Pharming Healthcare, Inc. | 4 | $159 |
| Genentech USA, Inc. | 3 | $93 |
| CSL Behring | 3 | $65 |
| Novartis Pharmaceuticals Corporation | 3 | $54 |
| GC Biopharma USA, Inc. | 3 | $49 |
| UCB, Inc. | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
Products named: Sajazir, ORLADEYO, DUPIXENT, Xolair, AYVAKIT, TEZSPIRE, ALYGLO, Bimzelx.
Industry payments across CO — which companies pay providers there.
